Additionally, Ferrara et al. showed that the presence of baseline senescent CD8+ T cell population (characterized by low proliferation, CD28-, CD57+, KLRG+) was associated with shorter PFS, shorter OS and lower objective responses in NSCLC patients treated with ICI [119]. This evidence concerns the gene CD8A and non-small cell lung carcinoma.